Blood Vessel “Doorway” Lets Breast Cancer Cells Spread Through Blood Stream
News Aug 13, 2015
Using real-time, high-resolution imaging, scientists have identified how a “doorway” in the blood vessel wall allows cancer cells to spread from breast tumors to other parts of the body. The findings lend support to emerging tests that better predict whether breast cancer will spread, which could spare women from invasive and unnecessary treatments, and could lead to new anti-cancer therapies. The research, conducted by investigators at the NCI-designated Albert Einstein Cancer Center (AECC) and Montefiore Einstein Center for Cancer Care, utilized a mouse model of human breast cancer and mice implanted with human breast tissue.
John Condeelis, Ph.D.The Einstein-Montefiore researchers previously found that breast cancer spreads when three specific cells are in direct contact: an endothelial cell (a type of cell that lines the blood vessels), a perivascular macrophage (a type of immune cell found near blood vessels), and a tumor cell that produces high levels of Mena, a protein that enhances a cancer cell’s ability to invade. The site where these three cells come in direct and stable contact––called a tumor microenvironment of metastasis, or TMEM––is where tumor cells enter blood vessels.
“It has been known for some time that blood vessels in tumors are abnormally permeable. But what regulates that permeability hasn’t been clear. Based on our latest imaging studies, we can now say that this phenomenon is regulated by TMEM macrophages,” said lead author Allison Harney, Ph.D., Bridge Postdoctoral Fellow in the Integrated Imaging Program at Albert Einstein College of Medicine.
This new research indicates that the TMEM macrophage releases a protein called vascular endothelial growth factor, or VEGF, which causes a local increase in blood vessel permeability. The effect is temporary but can last long enough to allow cancer cells to enter the blood stream—escaping the primary tumor and traveling to distant metastatic sites.
The researchers also observed for the first time that transient blood vessel permeability and tumor cell entry into the bloodstream occur simultaneously and exclusively at TMEM sites. The discovery was made using intravital high-resolution two-photon microscopy to image primary breast cancer tumors in mice and human xenografts (human breast cancer tissue grafted into mice).
“The discovery of a unique doorway that allows tumor cells into the blood stream opens new opportunities for the development of anti-metastasis therapeutics” said study leader John Condeelis, Ph.D., professor and co-chair of anatomy and structural biology, co-director of the Gruss Lipper Biophotonics Center and the Integrated Imaging Program, and the Judith and Burton P. Resnick Chair in Translational Research at Einstein and leader of the Tumor Microenvironment and Metastasis Program at AECC.
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers say they have identified that target - an enzyme called PPT1 - opening up a new pathway for potential cancer treatments.READ MORE